Beta-1 adrenergic receptor

Details

Name
Beta-1 adrenergic receptor
Synonyms
  • ADRB1R
  • B1AR
  • Beta-1 adrenoceptor
  • Beta-1 adrenoreceptor
Gene Name
ADRB1
Organism
Humans
Amino acid sequence
>lcl|BSEQ0010188|Beta-1 adrenergic receptor MGAGVLVLGASEPGNLSSAAPLPDGAATAARLLVPASPPASLLPPASESPEPLSQQWTAG MGLLMALIVLLIVAGNVLVIVAIAKTPRLQTLTNLFIMSLASADLVMGLLVVPFGATIVV WGRWEYGSFFCELWTSVDVLCVTASIETLCVIALDRYLAITSPFRYQSLLTRARARGLVC TVWAISALVSFLPILMHWWRAESDEARRCYNDPKCCDFVTNRAYAIASSVVSFYVPLCIM AFVYLRVFREAQKQVKKIDSCERRFLGGPARPPSPSPSPVPAPAPPPGPPRPAAAAATAP LANGRAGKRRPSRLVALREQKALKTLGIIMGVFTLCWLPFFLANVVKAFHRELVPDRLFV FFNWLGYANSAFNPIIYCRSPDFRKAFQRLLCCARRAARRRHATHGDRPRASGCLARPGP PPSPGAASDDDDDDVVGATPPARLLEPWAGCNGGAAADSDSSLDEPCRPGFASESKV
数量的残留物
477
摩尔cular Weight
51322.1
Theoretical pI
9.03
GO Classification
Functions
alpha-2A adrenergic receptor binding/beta-adrenergic receptor activity/beta1-adrenergic receptor activity/epinephrine binding/去甲肾上腺素结合/PDZ domain binding/protein heterodimerization activity/Ras guanyl-nucleotide exchange factor activity/receptor signaling protein activity
Processes
activation of adenylate cyclase activity/adenylate cyclase-activating adrenergic receptor signaling pathway/brown fat cell differentiation/cell-cell signaling/diet induced thermogenesis/fear response/heat generation/intracellular signal transduction/negative regulation of multicellular organism growth/positive regulation of cAMP biosynthetic process/positive regulation of cAMP-mediated signaling/positive regulation of GTPase activity/positive regulation of heart rate by epinephrine-norepinephrine/positive regulation of the force of heart contraction by epinephrine-norepinephrine/response to cold/temperature homeostasis/vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure
Components
早期内体/integral component of plasma membrane/plasma membrane
General Function
Receptor signaling protein activity
Specific Function
Beta-adrenergic receptors mediate the catecholamine-induced activation of adenylate cyclase through the action of G proteins. This receptor binds epinephrine and norepinephrine with approximately equal affinity. Mediates Ras activation through G(s)-alpha- and cAMP-mediated signaling.
Pfam Domain Function
Transmembrane Regions
56-84 94-120 133-154 173-196 223-248 320-349 355-377
Cellular Location
Cell membrane
Gene sequence
>lcl|BSEQ0010189|Beta-1 adrenergic receptor (ADRB1) ATGGGCGCGGGGGTGCTCGTCCTGGGCGCCTCCGAGCCCGGTAACCTGTCGTCGGCCGCA CCGCTCCCCGACGGCGCGGCCACCGCGGCGCGGCTGCTGGTGCCCGCGTCGCCGCCCGCC TCGTTGCTGCCTCCCGCCAGCGAAAGCCCCGAGCCGCTGTCTCAGCAGTGGACAGCGGGC ATGGGTCTGCTGATGGCGCTCATCGTGCTGCTCATCGTGGCGGGCAATGTGCTGGTGATC GTGGCCATCGCCAAGACGCCGCGGCTGCAGACGCTCACCAACCTCTTCATCATGTCCCTG GCCAGCGCCGACCTGGTCATGGGGCTGCTGGTGGTGCCGTTCGGGGCCACCATCGTGGTG TGGGGCCGCTGGGAGTACGGCTCCTTCTTCTGCGAGCTGTGGACCTCAGTGGACGTGCTG TGCGTGACGGCCAGCATCGAGACCCTGTGTGTCATTGCCCTGGACCGCTACCTCGCCATC ACCTCGCCCTTCCGCTACCAGAGCCTGCTGACGCGCGCGCGGGCGCGGGGCCTCGTGTGC ACCGTGTGGGCCATCTCGGCCCTGGTGTCCTTCCTGCCCATCCTCATGCACTGGTGGCGG GCGGAGAGCGACGAGGCGCGCCGCTGCTACAACGACCCCAAGTGCTGCGACTTCGTCACC AACCGGGCCTACGCCATCGCCTCGTCCGTAGTCTCCTTCTACGTGCCCCTGTGCATCATG GCCTTCGTGTACCTGCGGGTGTTCCGCGAGGCCCAGAAGCAGGTGAAGAAGATCGACAGC TGCGAGCGCCGTTTCCTCGGCGGCCCAGCGCGGCCGCCCTCGCCCTCGCCCTCGCCCGTC CCCGCGCCCGCGCCGCCGCCCGGACCCCCGCGCCCCGCCGCCGCCGCCGCCACCGCCCCG CTGGCCAACGGGCGTGCGGGTAAGCGGCGGCCCTCGCGCCTCGTGGCCCTGCGCGAGCAG AAGGCGCTCAAGACGCTGGGCATCATCATGGGCGTCTTCACGCTCTGCTGGCTGCCCTTC TTCCTGGCCAACGTGGTGAAGGCCTTCCACCGCGAGCTGGTGCCCGACCGCCTCTTCGTC TTCTTCAACTGGCTGGGCTACGCCAACTCGGCCTTCAACCCCATCATCTACTGCCGCAGC CCCGACTTCCGCAAGGCCTTCCAGGGACTGCTCTGCTGCGCGCGCAGGGCTGCCCGCCGG CGCCACGCGACCCACGGAGACCGGCCGCGCGCCTCGGGCTGTCTGGCCCGGCCCGGACCC CCGCCATCGCCCGGGGCCGCCTCGGACGACGACGACGACGATGTCGTCGGGGCCACGCCG CCCGCGCGCCTGCTGGAGCCCTGGGCCGGCTGCAACGGCGGGGCGGCGGCGGACAGCGAC TCGAGCCTGGACGAGCCGTGCCGCCCCGGCTTCGCCTCGGAATCCAAGGTGTAG
Chromosome Location
10
Locus
10q24-q26
External Identifiers
Resource Link
UniProtKB ID P08588
UniProtKB Entry Name ADRB1_HUMAN
GenBank Protein ID 178200
GenBank Gene ID J03019
GenAtlas ID ADRB1
HGNC ID HGNC:285
General References
  1. Frielle T, Collins S, Daniel KW, Caron MG, Lefkowitz RJ, Kobilka BK: Cloning of the cDNA for the human beta 1-adrenergic receptor. Proc Natl Acad Sci U S A. 1987 Nov;84(22):7920-4. [Article]
  2. Moore JD, Mason DA, Green SA, Hsu J, Liggett SB: Racial differences in the frequencies of cardiac beta(1)-adrenergic receptor polymorphisms: analysis of c145A>G and c1165G>C. Hum Mutat. 1999 Sep 19;14(3):271. [Article]
  3. Deloukas P, Earthrowl ME, Grafham DV, Rubenfield M, French L, Steward CA, Sims SK, Jones MC, Searle S, Scott C, Howe K, Hunt SE, Andrews TD, Gilbert JG, Swarbreck D, Ashurst JL, Taylor A, Battles J, Bird CP, Ainscough R, Almeida JP, Ashwell RI, Ambrose KD, Babbage AK, Bagguley CL, Bailey J, Banerjee R, Bates K, Beasley H, Bray-Allen S, Brown AJ, Brown JY, Burford DC, Burrill W, Burton J, Cahill P, Camire D, Carter NP, Chapman JC, Clark SY, Clarke G, Clee CM, Clegg S, Corby N, Coulson A, Dhami P, Dutta I, Dunn M, Faulkner L, Frankish A, Frankland JA, Garner P, Garnett J, Gribble S, Griffiths C, Grocock R, Gustafson E, Hammond S, Harley JL, Hart E, Heath PD, Ho TP, Hopkins B, Horne J, Howden PJ, Huckle E, Hynds C, Johnson C, Johnson D, Kana A, Kay M, Kimberley AM, Kershaw JK, Kokkinaki M, Laird GK, Lawlor S, Lee HM, Leongamornlert DA, Laird G, Lloyd C, Lloyd DM, Loveland J, Lovell J, McLaren S, McLay KE, McMurray A, Mashreghi-Mohammadi M, Matthews L, Milne S, Nickerson T, Nguyen M, Overton-Larty E, Palmer SA, Pearce AV, Peck AI, Pelan S, Phillimore B, Porter K, Rice CM, Rogosin A, Ross MT, Sarafidou T, Sehra HK, Shownkeen R, Skuce CD, Smith M, Standring L, Sycamore N, Tester J, Thorpe A, Torcasso W, Tracey A, Tromans A, Tsolas J, Wall M, Walsh J, Wang H, Weinstock K, West AP, Willey DL, Whitehead SL, Wilming L, Wray PW, Young L, Chen Y, Lovering RC, Moschonas NK, Siebert R, Fechtel K, Bentley D, Durbin R, Hubbard T, Doucette-Stamm L, Beck S, Smith DR, Rogers J: The DNA sequence and comparative analysis of human chromosome 10. Nature. 2004 May 27;429(6990):375-81. [Article]
  4. Pak Y, Pham N, Rotin D: Direct binding of the beta1 adrenergic receptor to the cyclic AMP-dependent guanine nucleotide exchange factor CNrasGEF leads to Ras activation. Mol Cell Biol. 2002 Nov;22(22):7942-52. [Article]
  5. He J, Bellini M, Xu J, Castleberry AM, Hall RA: Interaction with cystic fibrosis transmembrane conductance regulator-associated ligand (CAL) inhibits beta1-adrenergic receptor surface expression. J Biol Chem. 2004 Nov 26;279(48):50190-6. Epub 2004 Sep 9. [Article]
  6. Cheng SB, Quinn JA, Graeber CT, Filardo EJ: Down-modulation of the G-protein-coupled estrogen receptor, GPER, from the cell surface occurs via a trans-Golgi-proteasome pathway. J Biol Chem. 2011 Jun 24;286(25):22441-55. doi: 10.1074/jbc.M111.224071. Epub 2011 May 2. [Article]
  7. Mason DA, Moore JD, Green SA, Liggett SB: A gain-of-function polymorphism in a G-protein coupling domain of the human beta1-adrenergic receptor. J Biol Chem. 1999 Apr 30;274(18):12670-4. [Article]
  8. Borjesson M, Magnusson Y, Hjalmarson A, Andersson B: A novel polymorphism in the gene coding for the beta(1)-adrenergic receptor associated with survival in patients with heart failure. Eur Heart J. 2000 Nov;21(22):1853-8. [Article]
  9. Ranade K, Jorgenson E, Sheu WH, Pei D, Hsiung CA, Chiang FT, Chen YD, Pratt R, Olshen RA, Curb D, Cox DR, Botstein D, Risch N: A polymorphism in the beta1 adrenergic receptor is associated with resting heart rate. Am J Hum Genet. 2002 Apr;70(4):935-42. Epub 2002 Feb 18. [Article]

Drug Relations

Drug Relations
DrugBank ID Name Drug group Pharmacological action? Actions Details
DB00187 Esmolol approved, withdrawn yes antagonist Details
DB00195 Betaxolol approved, investigational yes antagonist Details
DB00221 Isoetharine approved yes agonist Details
DB00264 Metoprolol approved, investigational yes antagonist Details
DB00335 Atenolol approved yes antagonist Details
DB00373 Timolol approved yes antagonist Details
DB00571 Propranolol approved, investigational yes antagonist Details
DB00612 Bisoprolol approved yes antagonist Details
DB00841 Dobutamine approved yes agonist Details
DB00866 Alprenolol experimental, withdrawn yes antagonist Details
DB00960 心得乐 approved, investigational yes partial agonist Details
DB01064 Isoprenaline approved, investigational yes agonist Details
DB01102 Arbutamine approved yes agonist Details
DB01193 Acebutolol approved, investigational yes partial agonist Details
DB01203 Nadolol approved yes antagonist Details
DB01210 Levobunolol approved yes antagonist Details
DB01214 Metipranolol approved yes antagonist Details
DB00521 Carteolol approved yes partial agonist Details
DB00598 Labetalol approved yes antagonist Details
DB00668 Epinephrine approved, vet_approved yes agonist Details
DB01136 Carvedilol approved, investigational yes antagonist Details
DB01151 Desipramine approved, investigational unknown other Details
DB01295 Bevantolol experimental yes antagonist Details
DB01297 Practolol approved yes antagonist Details
DB01580 Oxprenolol approved yes antagonist Details
DB01359 Penbutolol approved, investigational yes antagonistpartial agonist Details
DB00368 Norepinephrine approved yes agonist Details
DB04855 Dronedarone approved unknown antagonist Details
DB04861 Nebivolol approved, investigational yes antagonist Details
DB06262 Droxidopa approved, investigational yes agonist Details
18beplay下载 Salbutamol approved, vet_approved unknown agonist 18beplay下载
DB00489 Sotalol approved yes antagonist Details
DB01291 Pirbuterol approved unknown agonist Details
DB01288 Fenoterol approved, investigational unknown agonist Details
DB00397 Phenylpropanolamine 批准、vet_approved撤回 unknown agonist Details
DB01407 Clenbuterol approved, investigational, vet_approved unknown agonist Details
DB08347 4-{[(2S)-3-(tert-butylamino)-2-hydroxypropyl]oxy}-3H-indole-2-carbonitrile experimental unknown Details
DB08558 2-HYDROXYMETHYL-6-OCTYLSULFANYL-TETRAHYDRO-PYRAN-3,4,5-TRIOL experimental unknown Details
DB08807 Bopindolol experimental yes partial agonist Details
DB08808 Bupranolol experimental yes antagonist Details
DB00852 Pseudoephedrine approved unknown agonistpartial agonist Details
DB04846 Celiprolol approved, investigational yes antagonist Details
DB01363 Ephedra sinica root nutraceutical yes agonist Details
DB06216 Asenapine approved unknown antagonist Details
DB00408 Loxapine approved unknown binder Details
DB00248 Cabergoline approved unknown binder Details
DB09068 Vortioxetine approved, investigational unknown ligand Details
DB09013 Befunolol experimental unknown Details
DB00983 Formoterol approved, investigational unknown agonist Details
DB00938 Salmeterol approved unknown inverse agonist Details
DB00871 Terbutaline approved unknown antagonist Details
DB01917 Putrescine experimental unknown Details
DB03566 Spermidine experimental unknown Details
DB00127 Spermine experimental, nutraceutical unknown Details
DB01182 Propafenone approved unknown antagonist Details
DB09351 Levobetaxolol approved, investigational yes antagonist Details
DB13781 Xamoterol approved yes partial agonist Details
DB09204 Arotinolol investigational yes antagonist Details
DB00555 Lamotrigine approved, investigational unknown 抑制剂 Details
DB11124 Racepinephrine approved yes agonist Details
DB11278 DL-Methylephedrine approved yes agonist Details
DB00243 Ranolazine approved, investigational no antagonist Details
DB01238 Aripiprazole approved, investigational unknown ligand Details
DB01364 Ephedrine approved yes agonist Details
DB08893 Mirabegron approved unknown agonist Details
DB01118 Amiodarone approved, investigational yes 抑制剂downregulator Details
DB00182 Amphetamine approved, illicit, investigational unknown agonist Details
DB00540 Nortriptyline approved unknown antagonist Details
DB00726 Trimipramine approved unknown binder Details
DB00334 Olanzapine approved, investigational no 抑制剂 Details
DB00217 Bethanidine approved unknown antagonist Details
DB01365 Mephentermine approved unknown agonist Details
DB06726 Bufuralol experimental unknown antagonist Details
DB13345 Dihydroergocristine approved, experimental yes antagonistagonist Details
DB01049 Ergoloid mesylate approved yes antagonistagonist Details
DB11273 Dihydroergocornine approved yes antagonistagonist Details
DB11278 DL-Methylephedrine approved yes agonist Details
DB00715 Paroxetine approved, investigational unknown 抑制剂 Details
DB00785 Cryptenamine approved unknown 抑制剂potentiator Details
DB00867 Ritodrine approved, investigational yes agonistdownregulator Details
DB00264 Metoprolol approved, investigational unknown 抑制剂 Details